Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 39,532 | 15,538 | 12,261 | -19,553 | -263,603 |
| Depreciation Amortization | 157,153 | 107,353 | 58,571 | 20,541 | 43,282 |
| Income taxes - deferred | -180,549 | -134,014 | N/A | N/A | -7,516 |
| Accounts receivable | -124,766 | -135,370 | -97,167 | -53,443 | -46,183 |
| Accounts payable and accrued liabilities | -8,362 | 38,213 | 1,604 | -18 | 9,383 |
| Other Working Capital | 1,130 | -36,468 | -175,228 | -87,232 | 14,059 |
| Other Operating Activity | 310,028 | 203,976 | 170,804 | 68,966 | 278,127 |
| Operating Cash Flow | $194,166 | $59,228 | $-29,155 | $-70,739 | $27,549 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 64,623 | 64,623 | 64,623 | N/A | N/A |
| PPE Investments | -7,156 | -4,514 | -2,281 | -1,577 | -3,500 |
| Net Acquisitions | -1,022,361 | -1,022,361 | -1,022,361 | N/A | -224,220 |
| Purchase Of Investment | -71,813 | -71,813 | N/A | N/A | N/A |
| Sale Of Investment | 42,781 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -1,122 | -122 | 138 | 138 | 0 |
| Investing Cash Flow | $-995,048 | $-1,034,187 | $-959,881 | $-1,439 | $-227,720 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,241,027 | 1,241,027 | 1,241,240 | 388,000 | 286,966 |
| Debt Repayment | -299,000 | -298,000 | -297,000 | N/A | N/A |
| Common Stock Issued | 503,478 | 499,894 | 495,749 | 11,713 | 42,828 |
| Other Financing Activity | -3,024 | -2,334 | -1,956 | -1,215 | 8,491 |
| Financing Cash Flow | $1,442,481 | $1,440,587 | $1,438,033 | $398,498 | $338,285 |
| Exchange Rate Effect | -790 | -149 | -747 | -916 | 213 |
| Beginning Cash Position | 218,807 | 218,807 | 218,807 | 218,807 | 80,480 |
| End Cash Position | 859,616 | 684,286 | 667,057 | 544,211 | 218,807 |
| Net Cash Flow | $640,809 | $465,479 | $448,250 | $325,404 | $138,327 |
| Free Cash Flow | |||||
| Operating Cash Flow | 194,166 | 59,228 | -29,155 | -70,739 | 27,549 |
| Capital Expenditure | -7,156 | -4,514 | -2,281 | -1,577 | -3,500 |
| Free Cash Flow | 187,010 | 54,714 | -31,436 | -72,316 | 24,049 |